AMRN vs. MIRA
AMRN (Amarin Corporation plc) and MIRA (MIRA Pharmaceuticals Inc. Common Stock) are both stocks. Both are in the Healthcare sector — AMRN in Biotechnology, MIRA in Drug Manufacturers - General. Over the past year, AMRN returned -5.94% vs -48.57% for MIRA. Their 0.15 correlation means their historical movements had little consistent relationship.
Performance
AMRN vs. MIRA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AMRN achieves a 2.19% return, which is significantly higher than MIRA's -47.55% return.
AMRN
- 1D
- 0.21%
- 1M
- -12.89%
- 6M
- -4.42%
- YTD
- 2.19%
- 1Y
- -5.94%
- 3Y*
- -15.70%
- 5Y*
- -29.66%
- 10Y*
- -13.89%
- ALL TIME*
- -18.30%
MIRA
- 1D
- -2.98%
- 1M
- -16.17%
- 6M
- -36.13%
- YTD
- -47.55%
- 1Y
- -48.57%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- -51.72%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $774.72K | $965.69K | $1.09M | |
| $48.29K | $55.07K | $96.54K |
AMRN vs. MIRA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
AMRN Amarin Corporation plc | 2.19% | 43.87% | -44.25% | -26.89% |
MIRA MIRA Pharmaceuticals Inc. Common Stock | -47.55% | 32.46% | 8.57% | -85.00% |
Correlation
The correlation between AMRN and MIRA is 0.12, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.12 |
Correlation (All Time) Calculated using the full available price history since Aug 3, 2023 | 0.15 |
Fundamentals
AMRN:
$294.94M
MIRA:
$33.28M
AMRN:
-$0.23
MIRA:
-$1.47
AMRN:
$181.22M
MIRA:
$0.00
AMRN:
$77.40M
MIRA:
$0.00
AMRN:
-$24.61M
MIRA:
-$6.93M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AMRN vs. MIRA — Risk / Return Rank
AMRN
MIRA
AMRN vs. MIRA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Amarin Corporation plc (AMRN) and MIRA Pharmaceuticals Inc. Common Stock (MIRA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AMRN | MIRA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.67 | ||
| Sortino ratioReturn per unit of downside risk | +1.39 | ||
| Omega ratioGain probability vs. loss probability | 1.03 | 0.88 | +0.16 |
| Calmar ratioReturn relative to maximum drawdown | -0.05 | -0.93 | +0.88 |
| Martin ratioReturn relative to average drawdown | -0.08 | -1.61 | +1.53 |
Loading charts...
Drawdowns
AMRN vs. MIRA - Drawdown Comparison
The maximum AMRN drawdown since its inception was -99.97%, which is greater than MIRA's maximum drawdown of -92.69%. Use the drawdown chart below to compare losses from any high point for AMRN and MIRA.
Loading charts...
Drawdown Indicators
| AMRN | MIRA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.97% | -92.69% | -7.28% |
Max Drawdown (1Y)Largest decline over 1 year | -33.33% | -56.00% | +22.67% |
Max Drawdown (3Y)Largest decline over 3 years | -70.36% | -92.69% | +22.33% |
Max Drawdown (5Y)Largest decline over 5 years | -93.15% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -98.34% | — | — |
Current DrawdownCurrent decline from peak | -99.95% | -89.33% | -10.62% |
Average DrawdownAverage peak-to-trough decline | -90.44% | -78.76% | -11.68% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 23.15% | 32.46% | -9.31% |
Volatility
AMRN vs. MIRA - Volatility Comparison
The current volatility for Amarin Corporation plc (AMRN) is 7.37%, while MIRA Pharmaceuticals Inc. Common Stock (MIRA) has a volatility of 11.44%. This indicates that AMRN experiences smaller price fluctuations and is considered to be less risky than MIRA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AMRN | MIRA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.37% | 11.44% | -4.07% |
Volatility (6M)Calculated over the trailing 6-month period | 26.69% | 47.16% | -20.47% |
Volatility (1Y)Calculated over the trailing 1-year period | 44.74% | 73.32% | -28.58% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 69.24% | 385.18% | -315.94% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 121.51% | 385.18% | -263.67% |
Dividends
AMRN vs. MIRA - Dividend Comparison
Neither AMRN nor MIRA has paid dividends to shareholders.
Financials
AMRN vs. MIRA - Financials Comparison
This section allows you to compare key financial metrics between Amarin Corporation plc and MIRA Pharmaceuticals Inc. Common Stock. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
AMRN and MIRA have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MIRA has higher volatility (11.44%) compared to AMRN (7.37%). In terms of maximum drawdown, AMRN dropped -99.97% vs MIRA's -92.69%.
AMRN currently has the higher Sharpe Ratio (-0.04 vs -0.71), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AMRN and MIRA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer